keyword
MENU ▼
Read by QxMD icon Read
search

cytokine antipsychotic

keyword
https://www.readbyqxmd.com/read/28138204/a-case-of-olanzapine-induced-fever
#1
Cho-Hsiang Yang, Ying-Yeh Chen
Olanzapine, a frequently used second-generation antipsychotic, has rarely been implicated as a cause of drug-induced fever in the absence of neuroleptic malignant syndrome. We describe a patient who developed isolated fever following olanzapine monotherapy, which subsided after discontinuation of olanzapine. Blockade of dopaminergic receptors and elevated cytokines concentration are possible mechanisms of fever development during treatment with olanzapine. This case calls for attention to olanzapine-induced fever in clinical practice...
January 26, 2017: Psychopharmacology Bulletin
https://www.readbyqxmd.com/read/28093554/tumour-necrosis-factor-mediated-homeostatic-synaptic-plasticity-in-behavioural-models-testing-a-role-in-maternal-immune-activation
#2
Sarah C Konefal, David Stellwagen
The proinflammatory cytokine tumour necrosis factor-alpha (TNFα) has long been characterized for its role in the innate immune system, but more recently has been found to have a distinct role in the nervous system that does not overlap with other proinflammatory cytokines. Through regulation of neuronal glutamate and GABA receptor trafficking, TNF mediates a homeostatic form of synaptic plasticity, but plays no direct role in Hebbian forms of plasticity. As yet, there is no evidence to suggest that this adaptive plasticity plays a significant role in normal development, but it does maintain neuronal circuit function in the face of several types of disruption...
March 5, 2017: Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
https://www.readbyqxmd.com/read/27959331/cortical-grey-matter-volume-reduction-in-people-with-schizophrenia-is-associated-with-neuro-inflammation
#3
Y Zhang, V S Catts, D Sheedy, T McCrossin, J J Kril, C Shannon Weickert
Cortical grey matter volume deficits and neuro-inflammation exist in patients with schizophrenia, although it is not clear whether elevated cytokines contribute to the cortical volume reduction. We quantified cortical and regional brain volumes in fixed postmortem brains from people with schizophrenia and matched controls using stereology. Interleukin (IL)-6, IL-1β, IL-8 and SERPINA3 messenger RNAs (mRNAs) were quantified in the contralateral fresh frozen orbitofrontal cortex. We found a small, but significant reduction in cortical grey matter (1...
December 13, 2016: Translational Psychiatry
https://www.readbyqxmd.com/read/27776952/prolactin-gene-polymorphism-1149-g-t-is-associated-with-hyperprolactinemia-in-patients-with-schizophrenia-treated-with-antipsychotics
#4
Svetlana A Ivanova, Diana Z Osmanova, Anastasia S Boiko, Ivan V Pozhidaev, Maxim B Freidin, Olga Yu Fedorenko, Arkadiy V Semke, Nikolay A Bokhan, Elena G Kornetova, Lubov D Rakhmazova, Bob Wilffert, Anton J M Loonen
BACKGROUND: Antipsychotic drugs can cause hyperprolactinemia. However, hyperprolactinemia was also observed in treatment-naive patients with a first schizophrenic episode. This phenomenon might be related to the role of prolactin as a cytokine in autoimmune diseases. Extrapituitary prolactin production is regulated by an alternative promoter, which contains the functional single nucleotide polymorphism -1149 G/T (rs1341239). We examined whether this polymorphism was associated with hyperprolactinemia in patients with schizophrenia...
October 21, 2016: Schizophrenia Research
https://www.readbyqxmd.com/read/27711937/il-4-tgf-%C3%AF-nf-%C3%AF-b-and-mpo-levels-in-patients-with-treatment-resistant-schizophrenia
#5
Şükrü Kartalcı, Lale Gönenir Erbay, Esra Porgalı Zayman, Önder Otlu, Aysun Bay Karabulut, Gülşen Kartalcı
OBJECTIVE: Schizophrenia is a chronic psychotic disorder in which genetics and environmental factors such as infection and the corresponding immune response play a role in the etiopathogenesis. The aim of this study was to compare some immune factors such as nuclear factor-B (NF-B) activation, myeloperoxidase (MPO), the anti-inflammatory cytokine interleukin-4 (IL-4), and regulatory cytokine transforming growth factor- (TGF-) in schizophrenia patients and an age- and gender-matched control group...
2016: Türk Psikiyatri Dergisi, Turkish Journal of Psychiatry
https://www.readbyqxmd.com/read/27606316/inflammatory-cytokines-and-antipsychotic-induced-weight-gain-review-and-clinical-implications
#6
REVIEW
Trehani M Fonseka, Daniel J Müller, Sidney H Kennedy
Antipsychotic medications (APs), particularly second-generation APs, are associated with significant weight gain in schizophrenia patients. Recent evidence suggests that the immune system may contribute to antipsychotic-induced weight gain (AIWG) via AP-mediated alterations of cytokine levels. Antipsychotics with a high propensity for weight gain, such as clozapine and olanzapine, influence the expression of immune genes, and induce changes in serum cytokine levels to ultimately down-regulate neuroinflammation...
May 2016: Molecular Neuropsychiatry
https://www.readbyqxmd.com/read/27471446/taurine-and-epidermal-growth-factor-belong-to-the-signature-of-first-episode-psychosis
#7
Kati Koido, Jürgen Innos, Liina Haring, Mihkel Zilmer, Aigar Ottas, Eero Vasar
This study evaluated the levels of two amino acid derivatives taurine and spermine in first-episode psychosis (FEP) patients and their response to antipsychotic treatment. The levels of taurine and spermine were significantly up-regulated in antipsychotic-naïve FEP patients compared to control subjects (CS). Treatment of FEP patients with antipsychotic drugs significantly reduced the positive symptoms of schizophrenia. This positive effect was accompanied by a significant reduction of taurine and spermine to the levels measured in CS...
2016: Frontiers in Neuroscience
https://www.readbyqxmd.com/read/27470381/celecoxib-and-omega-3-fatty-acids-alone-and-in-combination-with-risperidone-affect-the-behavior-and-brain-biochemistry-in-amphetamine-induced-model-of-schizophrenia
#8
Alaa El-Sayed El-Sisi, Samia Salem Sokkar, Magda El-Sayed El-Sayad, Ehab Sayed Ramadan, Enass Yossef Osman
The implications of oxidative stress and neuro-inflammation in the pathogenesis of schizophrenia have been elucidated. Despite their effectiveness against positive symptoms of schizophrenia, antipsychotics have limited effectiveness against negative and cognitive symptoms and are associated with remarkable adverse effects. The use of celecoxib or omega-3 in schizophrenia may have beneficial effects. This study aimed to evaluate the possible efficacies of celecoxib, omega-3 or the combination of celecoxib+risperidone and omega-3+ risperidone compared to risperidone on the behavior and brain biochemistry in rats...
August 2016: Biomedicine & Pharmacotherapy, Biomédecine & Pharmacothérapie
https://www.readbyqxmd.com/read/27409727/relationships-between-serum-brain-derived-neurotrophic-factor-plasma-catecholamine-metabolites-cytokines-cognitive-function-and-clinical-symptoms-in-japanese-patients-with-chronic-schizophrenia-treated-with-atypical-antipsychotic-monotherapy
#9
Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, Kiyokazu Atake, Ryohei Igata, Yuki Konishi, Jun Nakamura
OBJECTIVES: Catecholamines, brain-derived neurotrophic factor (BDNF) and cytokines may be involved in the pathophysiology of schizophrenia. The aim of this study was to examine the associations between serum BDNF levels, plasma catecholamine metablolites, cytokines and the cognitive functions of patients with schizophrenia treated with atypical antipsychotic monotherapy. METHODS: One hundred and forty-six patients with schizophrenia and 51 age- and sex-matched healthy controls were examined for peripheral biological markers and neurocognitive test...
July 13, 2016: World Journal of Biological Psychiatry
https://www.readbyqxmd.com/read/27337797/-analysis-of-the-changes-of-serum-high-mobility-group-protein-b1-and-cytokines-in-first-episode-schizophrenia-patients
#10
Qiyu Zhu, Xue Li, Gangrui Hie, Xiuxia Yuan, Luxian Lü, Xueqin Song
OBJECTIVE: To measure serum levels of high mobility group protein B-1 (HMGB1), interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α ( TNF-α) before and after antipsychotic treatment, and further study the role of HMGB1 in schizophrenics. METHODS: Thirty first-episode schizophrenics who were never treated with neuroleptics from First Affiliated Hospital of Zhengzhou University and thirty healthy subjects were enrolled. Serum levels of cytokines such as HMGB1, IL-1β, IL-6 and TNF-α were examined with enzyme linked immunosorbent assay (ELISA) before and after antipsychotic treatment...
December 15, 2015: Zhonghua Yi Xue za Zhi [Chinese medical journal]
https://www.readbyqxmd.com/read/27233514/the-atypical-antipsychotic-paliperidone-regulates-endogenous-antioxidant-anti-inflammatory-pathways-in-rat-models-of-acute-and-chronic-restraint-stress
#11
Karina S MacDowell, Javier R Caso, David Martín-Hernández, Beatriz M Moreno, José L M Madrigal, Juan A Micó, Juan C Leza, Borja García-Bueno
Alterations in the innate inflammatory response may underlie the pathophysiology of psychiatric diseases. Current antipsychotics modulate pro-/anti-inflammatory pathways, but their specific actions on these pathways remain only partly explored. This study was conducted to elucidate the regulatory role of paliperidone (1 mg/kg i.p.) on acute (6 h) and chronic (6 h/day for 21 consecutive days) restraint stress-induced alterations in 2 emerging endogenous anti-inflammatory/antioxidant mechanisms: nuclear factor erythroid-related factor 2 (NRF2)/antioxidant enzymes pathway, and the cytokine milieu regulating M1/M2 polarization in microglia, analyzed at the mRNA and protein levels in prefrontal cortex samples...
October 2016: Neurotherapeutics: the Journal of the American Society for Experimental NeuroTherapeutics
https://www.readbyqxmd.com/read/27230882/alteration-of-cytokines-levels-in-the-striatum-of-rats-possible-participation-in-vacuous-chewing-movements-induced-by-antipsycotics
#12
Luis Ricardo Peroza, Larissa Finger Schaffer, Catiuscia Molz De Freitas, Caroline Queiroz Leal, Mayara Calegaro Ferrari, Marta Maria Frescura Duarte, Roselei Fachinetto
Antipsychotic drugs have been used in the treatment of schizophrenia and their long-term use can cause movement disorders, such as tardive dyskinesia (TD) in humans mainly typical ones such as haloperidol. Neuroinflammation has been implicated to the use of antipsychotics besides its participation in TD remains unclear. Thus, the aim of this study was to investigate the relation of cytokines with vacuous chewing movements (VCMs) in rats comparing typical and atypical antipsychotics. Rats were treated with haloperidol or risperidone for 28 days...
September 2016: Neurochemical Research
https://www.readbyqxmd.com/read/27177030/pro-inflammatory-cytokines-and-their-epistatic-interactions-in-genetic-susceptibility-to-schizophrenia
#13
Lekshmy Srinivas, Neetha N Vellichirammal, Ann Mary Alex, Chandrasekharan Nair, Indu V Nair, Moinak Banerjee
BACKGROUND: In schizophrenia, genetic background may provide a substrate for intrinsic maldevelopment of the brain through environmental influences, by recruiting neurotrophic factors and cytokines, to trigger the changes that lead to impaired neuronal functions. Cytokines being the key regulators of immune/inflammatory reactions are also known to influence the dopaminergic, noradrenergic, and serotonergic neurotransmission. Therefore, functional polymorphisms in cytokine genes may result in imbalances in the pro- and anti-inflammatory cytokine production...
2016: Journal of Neuroinflammation
https://www.readbyqxmd.com/read/27114618/cytokines-in-schizophrenia-hope-or-hype
#14
REVIEW
Maju Mathew Koola
Although there is a cumulative evidence for the inflammation pathophysiology in schizophrenia, it has not been conclusively proven yet. One reason for this is the lack of studies that have controlled for major confounding factors such as obesity, smoking, antipsychotic use, and stress. The studies in which the major confounding factors were controlled were done in subjects in acute relapse and in treatment-resistant schizophrenia. To date, no studies have been done in stable outpatients with schizophrenia controlling for major confounding factors...
March 2016: Indian Journal of Psychological Medicine
https://www.readbyqxmd.com/read/27080462/protective-effects-of-quetiapine-on-metabolic-and-inflammatory-abnormalities-in-schizophrenic-patients-during-exacerbated-stage
#15
Yu-Chen Kao, Chih-Yuan Ko, Sheng-Chiang Wang, Yia-Ping Liu
Inflammation has been considered important in the pathogenesis of schizophrenia. Increasing evidence reveals that patients with schizophrenia have abnormal expression of cytokines, which are related to development of metabolic abnormalities. Metabolic abnormality has become a critical issue, though its longitudinal relationship with the disorder, such as the antipsychotics influence, is unclear. We aimed to investigate whether abnormalities of metabolic parameters and cytokine levels in acute exacerbated schizophrenic patients existed, and whether intervention of antipsychotic could help...
April 30, 2016: Chinese Journal of Physiology
https://www.readbyqxmd.com/read/27073741/repurposing-psychiatric-medicines-to-target-activated-microglia-in-anxious-mild-cognitive-impairment-and-early-parkinson-s-disease
#16
REVIEW
Edward C Lauterbach
Anxiety is common in the Mild Cognitive Impairment (MCI) stage of Alzheimer's disease (AD) and the pre-motor stages of Parkinson's disease (PD). A concomitant and possible cause of this anxiety is microglial activation, also considered a key promoter of neurodegeneration in MCI and early PD via inflammatory mechanisms and the generation of degenerative proinflammatory cytokines. Psychiatric disorders, prevalent in AD and PD, are often treated with psychiatric drugs (psychotropics), raising the question of whether psychotropics might therapeutically affect microglial activation, MCI, and PD...
2016: American Journal of Neurodegenerative Disease
https://www.readbyqxmd.com/read/27057406/disequilibrium-of-cytokine-serum-levels-in-veterans-with-chronic-schizophrenia-medicated-with-antipsychotics-association-with-measures-of-excitement-and-hostility
#17
Dimitre H Dimitrov, Shuko Lee, Jesse Yantis, Craig Honaker, Roberta Coelho, Nicole Braida, Consuelo Walss-Bass
No abstract text is available yet for this article.
2015: Primary Care Companion to CNS Disorders
https://www.readbyqxmd.com/read/26994434/cytokines-brain-derived-neurotrophic-factor-and-c-reactive-protein-in-bipolar-i-disorder-results-from-a-prospective-study
#18
Anne Sophie Jacoby, Klaus Munkholm, Maj Vinberg, Bente Klarlund Pedersen, Lars Vedel Kessing
BACKGROUND: Peripheral blood brain-derived neurotrophic factor (BDNF) and inflammatory markers may reflect key pathophysiological mechanisms in bipolar disorder in relation to disease activity and neuroprogression. AIMS: To investigate whether neutrophins and inflammatory marker vary with mood states and are increased in patients with bipolar disorder type I during euthymia as well as in all affective states as a group, compared to levels in healthy control subjects...
June 2016: Journal of Affective Disorders
https://www.readbyqxmd.com/read/26712377/beneficial-effects-of-lycopene-against-haloperidol-induced-orofacial-dyskinesia-in-rats-possible-neurotransmitters-and-neuroinflammation-modulation
#19
Swati Datta, Sumit Jamwal, Rahul Deshmukh, Puneet Kumar
Tardive Dyskinesia is a severe side effect of chronic neuroleptic treatment consisting of abnormal involuntary movements, characterized by orofacial dyskinesia. The study was designed to investigate the protective effect of lycopene against haloperidol induced orofacial dyskinesia possibly by neurochemical and neuroinflammatory modulation in rats. Rats were administered with haloperidol (1mg/kg, i.p for 21 days) to induce orofacial dyskinesia. Lycopene (5 and 10mg/kg, p.o) was given daily 1hour before haloperidol treatment for 21 days...
January 15, 2016: European Journal of Pharmacology
https://www.readbyqxmd.com/read/26710531/-influence-of-adamantilbromphenylamine-on-parameters-of-immunity-and-symptoms-of-asthenia-in-patients-with-non-psychotic-mental-disorders
#20
T P Vetlugina, V B Nikitina, S A Sergeeva, M M Axenov, O A Lobacheva, D N Savochkina, E M Epanchintseva, N A Bokhan
OBJECTIVE: Our aim was to assess effect of antiasthenic drug adamantilbromphenylamine on the immune system and symptoms of asthenia in patients with non-psychotic mental disorders and to reveal possible criteria for prediction of treatment efficiency. METHODS: Uncontrolled study with interrupted time series was carried out. According to efficiency of treatment patients were divided into two groups (group 1 (n=21)--very much improved and much improved; group 2 (n=9)--minimally improved)...
2015: Vestnik Rossiĭskoĭ Akademii Meditsinskikh Nauk
keyword
keyword
109789
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"